Do we still need to debate the merits of pleurectomy/decortication vs. extrapleural pneumonectomy for malignant pleural mesothelioma?
- PMID: 36895923
- PMCID: PMC9989799
- DOI: 10.21037/tlcr-23-24
Do we still need to debate the merits of pleurectomy/decortication vs. extrapleural pneumonectomy for malignant pleural mesothelioma?
Keywords: Extrapleural pneumonectomy (EPP); immune checkpoint inhibitor; malignant pleural mesothelioma (MPM); pleurectomy/decortication (P/D).
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tlcr.amegroups.com/article/view/10.21037/tlcr-23-24/coif). The authors have no conflicts of interest to declare.
Comment on
-
Multimodal therapy of epithelioid pleural mesothelioma: improved survival by changing the surgical treatment approach.Transl Lung Cancer Res. 2022 Nov;11(11):2230-2242. doi: 10.21037/tlcr-22-199. Transl Lung Cancer Res. 2022. PMID: 36519024 Free PMC article.
References
-
- Rusch V, Baldini EH, Bueno R, et al. The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass. J Thorac Cardiovasc Surg 2013;145:909-10. - PubMed
-
- Friedberg JS, Culligan MJ, Tsao AS, et al. A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute-International Association for the Study of Lung Cancer-Mesothelioma Applied Research Foundation Taskforce. J Thorac Oncol 2019;14:1343-53. 10.1016/j.jtho.2019.04.029 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources